Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 8.1B | 8.7B | 7.8B |
Cost of revenue | 5.8B | 5.1B | 5.4B | 5.0B |
Gross profit | 3.5B | 3.0B | 3.3B | 2.7B |
Operating expense | ||||
Research & development | 965M | 898M | 888M | 903M |
Selling general and admin | 318M | 285M | 288M | 295M |
Other operating expenses | 56M | 7M | -2M | 12M |
Operating income | 2.2B | 1.8B | 2.2B | 1.5B |
Non operating interest income | ||||
Income | 135M | 108M | 107M | 131M |
Expense | 123M | 112M | 118M | 136M |
Other income expense | -68M | -11M | -11M | -12M |
Pretax income | 2.1B | 1.8B | 2.2B | 1.5B |
Tax provision | 235M | 177M | 283M | 623M |
Net income | 1.9B | 1.6B | 1.9B | 887M |
Basic EPS | 1.7 | 1.4 | 1.7 | 0.8 |
Diluted EPS | 1.7 | 1.4 | 1.7 | 0.8 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 4.3B | 3.9B | 4.3B | 3.6B |
Net income from continuing op. | 1.9B | 1.6B | 1.9B | 887M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |